IP vs MTNB
International Paper (IP) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the IP and MTNB stock pages for the full models.
Not investment advice.